GSK Awards $2M in Grant Funding for Programs Supporting Adult Vaccination, Commits Additional $2M for 2025
GSK has announced the distribution of nearly $2 million in grants to 15 non-profit and community-based organizations through its COiMMUNITY Initiative program. The funding aims to enhance adult immunization rates through improved vaccine education, outreach, and access in the United States.
Key recipients include Sepsis Alliance and Pennsylvania Pharmacists Association, focusing on connecting vaccination to sepsis prevention and promoting year-round vaccination efforts respectively. Other notable awardees include the American Heart Association, American Lung Association, and National Council on Aging.
Additionally, GSK has committed another $2 million for 2025 COiMMUNITY Initiative grants, with proposals being accepted through mid-November 2025 via gskgrants.com.
GSK ha annunciato la distribuzione di quasi 2 milioni di dollari in sovvenzioni a 15 organizzazioni non profit e comunitarie attraverso il suo programma COiMMUNITY Initiative. Il finanziamento mira a migliorare i tassi di immunizzazione degli adulti attraverso una migliore educazione sui vaccini, sensibilizzazione e accesso negli Stati Uniti.
I principali beneficiari includono Sepsis Alliance e Pennsylvania Pharmacists Association, con focus sulla connessione tra vaccinazione e prevenzione della sepsi e sulla promozione degli sforzi di vaccinazione durante tutto l'anno, rispettivamente. Altri premiati notevoli includono l'American Heart Association, l'American Lung Association e il National Council on Aging.
Inoltre, GSK ha impegnato ulteriori 2 milioni di dollari per le sovvenzioni del COiMMUNITY Initiative 2025, con proposte accettate fino a metà novembre 2025 tramite gskgrants.com.
GSK ha anunciado la distribución de casi 2 millones de dólares en subvenciones a 15 organizaciones sin fines de lucro y comunitarias a través de su programa COiMMUNITY Initiative. La financiación tiene como objetivo mejorar las tasas de inmunización en adultos mediante una mejor educación sobre vacunas, divulgación y acceso en los Estados Unidos.
Los principales beneficiarios incluyen Sepsis Alliance y Pennsylvania Pharmacists Association, enfocándose en conectar la vacunación con la prevención de sepsis y promover esfuerzos de vacunación durante todo el año, respectivamente. Otros premiados notables incluyen a la American Heart Association, la American Lung Association y el National Council on Aging.
Además, GSK se ha comprometido a destinar otros 2 millones de dólares para las subvenciones de la COiMMUNITY Initiative 2025, aceptando propuestas hasta mediados de noviembre de 2025 a través de gskgrants.com.
GSK는 COiMMUNITY Initiative 프로그램을 통해 15개의 비영리 및 지역 사회 기반 조직에 거의 200만 달러의 보조금을 배포한다고 발표했습니다. 이 자금은 미국 내 성인 예방 접종률을 향상시키기 위해 백신 교육, 홍보 및 접근성을 개선하는 것을 목표로 하고 있습니다.
주요 수혜자는 Sepsis Alliance와 Pennsylvania Pharmacists Association으로, 각각 예방 접종과 패혈증 예방을 연결하고 연중 예방 접종 노력을 촉진하는 데 중점을 두고 있습니다. 다른 주목할 만한 수상자로는 American Heart Association, American Lung Association, National Council on Aging이 있습니다.
또한, GSK는 2025년 COiMMUNITY Initiative 보조금에 대해 또 다른 200만 달러를 약속했으며, 제안서는 2025년 11월 중순까지 gskgrants.com을 통해 접수됩니다.
GSK a annoncé la distribution de près de 2 millions de dollars en subventions à 15 organisations à but non lucratif et communautaires dans le cadre de son programme COiMMUNITY Initiative. Le financement vise à améliorer les taux de vaccination des adultes grâce à une meilleure éducation sur les vaccins, sensibilisation et accès aux États-Unis.
Les principaux bénéficiaires incluent Sepsis Alliance et Pennsylvania Pharmacists Association, se concentrant respectivement sur la connexion entre la vaccination et la prévention de la sepsie, ainsi que sur la promotion des efforts de vaccination tout au long de l'année. D'autres lauréats notables incluent l'American Heart Association, l'American Lung Association et le National Council on Aging.
De plus, GSK s'est engagé à allouer encore 2 millions de dollars pour les subventions de l'initiative COiMMUNITY 2025, avec des propositions acceptées jusqu'à la mi-novembre 2025 via gskgrants.com.
GSK hat die Verteilung von fast 2 Millionen Dollar an 15 gemeinnützige und gemeinschaftsbasierte Organisationen im Rahmen seines COiMMUNITY Initiative-Programms bekannt gegeben. Die Finanzierung zielt darauf ab, die Impfquote bei Erwachsenen durch verbesserte Impfaufklärung, Öffentlichkeitsarbeit und Zugang in den Vereinigten Staaten zu erhöhen.
Zu den wichtigsten Empfängern gehören Sepsis Alliance und Pennsylvania Pharmacists Association, die sich jeweils auf die Verbindung zwischen Impfungen und der Prävention von Sepsis sowie die Förderung von Impfaktionen das ganze Jahr über konzentrieren. Weitere bemerkenswerte Preisträger sind die American Heart Association, die American Lung Association und der National Council on Aging.
Darüber hinaus hat GSK weitere 2 Millionen Dollar für die COiMMUNITY Initiative-Stipendien 2025 zugesagt, wobei Vorschläge bis Mitte November 2025 über gskgrants.com angenommen werden.
- Commitment of $4M total in grant funding ($2M for 2024 and $2M for 2025)
- Strategic partnership with 15 established healthcare organizations for vaccine education and access
- Expansion of vaccination outreach programs to improve adult immunization rates
- None.
Insights
GSK's $4M commitment to adult vaccination education represents a strategic market development initiative rather than a financially material investment. With a $70.8B market cap, this $4M program (
This initiative exemplifies GSK's ecosystem approach to market development - addressing systemic barriers to adult vaccination through third-party organizations rather than direct promotion. By funding 15 diverse organizations like Sepsis Alliance and pharmacy associations, GSK is cultivating multiple channels to drive vaccine awareness and accessibility.
The focus on adult immunization specifically targets an underpenetrated market where vaccination rates historically lag pediatric levels. This represents a targeted effort to grow the overall market rather than simply competing for market share within the existing demand pool.
While impossible to quantify precise ROI, these relationships with influential healthcare organizations create valuable touchpoints throughout the healthcare ecosystem. This positions GSK as a public health partner while simultaneously developing markets for their commercial vaccine portfolio - a dual-purpose initiative that balances public health with business development.
GSK's COiMMUNITY Initiative demonstrates an important recognition that vaccine hesitancy and access barriers require multi-faceted approaches beyond typical pharmaceutical marketing. The company has wisely distributed funds across organizations with different specialties - from disease-specific groups (Sepsis Alliance) to healthcare providers (Ryan Health) to professional associations (Pennsylvania Pharmacists Association).
The program's focus on year-round vaccination awareness addresses a significant challenge in adult immunization, where rates typically surge only during flu season while protection gaps persist for other preventable diseases. By supporting pharmacy-based initiatives specifically, GSK leverages the most accessible healthcare touchpoint for many Americans.
The initiative's emphasis on community-specific approaches rather than one-size-fits-all messaging acknowledges the complex social determinants affecting vaccination decisions. While the
For a company with significant vaccine assets, this represents appropriate investment in addressing structural barriers to preventative care adoption. However, the financial impact is minimal relative to GSK's overall operations and market position.
- GSK is funding public health organizations working to address US adult immunization gaps and increase community vaccine education, outreach and access
- These grants are part of GSK’s COiMMUNITY Initiative, which aims to address adult immunization barriers through funding, increased data transparency and resource-sharing opportunities
- The call for new COiMMUNITY Initiative grant proposals is now open
Leonard Friedland, VP and Director, Scientific Affairs and Public Health, Vaccines, GSK, said: “We are committed to ensuring people have access to clear, trustworthy information about vaccines so that they can make the best decisions for themselves and their families. The 2024 COiMMUNITY Initiative grant recipients have designed vaccine education, outreach and access programs with the needs of their specific communities in mind. By offering educational tools to individuals and healthcare providers, these organizations are empowering people to take control of their preventive health and make informed choices about vaccination.”
The 2024 COiMMUNITY Initiative grant recipients include Sepsis Alliance and Pennsylvania Pharmacists Association who complement one another’s efforts by approaching adult immunization gaps from different angles — from making the connection between vaccines and the prevention of a little-known but deadly illness to helping pharmacists make vaccination a year-round effort.
Thomas Heymann, President and CEO, Sepsis Alliance, said: “Each year, sepsis kills more people than cancer. Since sepsis results from the body’s overreaction to an infection, vaccination could have potentially prevented many of these cases. This grant funding will help us spread the word about the value of vaccination for sepsis prevention through social media, web resources and PSAs on billboards and transit shelters in low-vaccination areas.”
“Adult immunization rates tend to rise and fall with the seasons, even though most vaccines are not inherently seasonal. With GSK’s support, we are equipping pharmacies across the Commonwealth with the tools they need to encourage year-round vaccination so that we don't miss out on opportunities for protection,” said Victoria Elliott, CEO, Pennsylvania Pharmacists Association (PPA). “PPA’s COiMMUNITY grant efforts include education to assist in targeted year-round outreach and technology to identify eligible recipients and help track vaccinations.”
Other awardees for 2024 are American Heart Association, American Lung Association, American Pharmacists Association, Asthma and Allergy Foundation of America, Autism Society, Ever Thrive Illinois, Global Healthy Living Foundation, Indiana Immunization Coalition, National Council on Aging, National Foundation for Infectious Diseases, Pharmacy Society of
Call for 2025 COiMMUNITY Initiative Grant Proposals
This year, GSK will be awarding another
About the COiMMUNITY Initiative
GSK’s COiMMUNITY Initiative aims to address long-standing barriers to adult immunization in the US through funding, increased data transparency and resource-sharing opportunities. Since the start of the COiMMUNITY Initiative grant program in 2023, GSK has awarded a total of
About GSK
GSK is a global biopharma company with a purpose to unite science, technology, and talent to get ahead of disease together. Find out more at gsk.com.
Cautionary statement regarding forward-looking statements
GSK cautions investors that any forward-looking statements or projections made by GSK, including those made in this announcement, are subject to risks and uncertainties that may cause actual results to differ materially from those projected. Such factors include, but are not limited to, those described under Item 3.D “Risk factors” in GSK’s Annual Report on Form 20-F for 2024.
Registered in
No. 3888792
Registered Office:
79 New Oxford Street
WC1A 1DG
View source version on businesswire.com: https://www.businesswire.com/news/home/20250408389277/en/
GSK inquiries
Media:
Kathleen Quinn +1 202 603 5003 (
Kate Kanaby +1 484 843 0993 (
Investor Relations:
Jeff McLaughlin +1 215 751 7002 (
Frannie DeFranco +1 215 751 4855 (
Source: GSK plc
FAQ
How much funding did GSK allocate for adult vaccination programs in 2024?
What is the purpose of GSK's COiMMUNITY Initiative grant program?
Which organizations received GSK's COiMMUNITY Initiative grants for 2024?
How can organizations apply for GSK's 2025 COiMMUNITY Initiative grants?
